Compare Edwards Lifesciences Corporation Common Stock (EW) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Sezzle Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Sezzle Inc trades at $118.49 (market cap $3.83B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 12.9× Sezzle Inc's market cap, and Sezzle Inc is more actively traded (341,401 versus 3,508,027). Which is the better fit depends on your goals.
| EW | SEZL | |
|---|---|---|
Market Cap | $49.44B | $3.83B |
Volume | 3,508,027 | 341,401 |
Sector | Health | Financials |
52-Week High | $95.18 | $188.55 |
52-Week Low | $72.65 | $50.97 |
Enterprise Value | $45.90B | $3.88B |
Typical Hold Time | — | 15 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Sezzle (SEZL) trades at $113.85, up 0.9% with a bullish technical outlook supported by strong moving averages and ADX signals. The company demonstrates exceptional profitability with 30.35% net margins and 88.85% ROE, having beaten earnings estimates for three consecutive quarters. Recent product launches including Sezzle Send and SezzleCash are driving user growth and platform engagement.
With 67% analyst buy ratings and a $168 consensus price target suggesting 48% upside, SEZL presents growth potential despite competitive BNPL pressures. Key risks include sector volatility and execution challenges in scaling new products. The stock's current valuation at 24.97 P/E appears reasonable given its growth trajectory and profitability metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
